Skip to main content
Clinical Trials/JPRN-UMIN000016893
JPRN-UMIN000016893
Completed
Phase 2

A double-blind, randomized clinical trial to evaluate the efficacy of Duloxetine against pain associated with Parkinson's disease with depression. - Pain reduction in PD patients with depression: double blind, randomized clinical trial of duloxetine.

Ehime University Hospital Dept. of Clinical pharmacology and Neurology0 sites50 target enrollmentApril 1, 2015
ConditionsPD patients

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
PD patients
Sponsor
Ehime University Hospital Dept. of Clinical pharmacology and Neurology
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2015
End Date
September 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ehime University Hospital Dept. of Clinical pharmacology and Neurology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \-Concomitant use of duloxetine within 2 weeks \-Subject with contraindication to duloxetine \-Suicidal ideation \-Renal transplantation or dialysis therapy \-History of any kidney diseases or baseline creatinine clearance below 30 (mL/min/1\.73 m2\) \-Woman who are pregnant or lactating \-Evidence of clinically significant disease \- Subjects on antipsychotics \-Have had multiple drug allergies or a severe drug reaction \-History of drug or alcohol dependency or abuse \-History of treatment with antipsychotics within 1 year before Visit 1 \- Other inadequate status for clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials